Literature DB >> 12790166

Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.

A L Reis1, J Carvalheira, F C Schmitt, F Gärtner.   

Abstract

To investigate the possible role of E-cadherin in canine mammary tumours 20 benign and 40 malignant tumours were evaluated by immunohistochemistry in formalin-fixed paraffin wax-embedded samples. In all the benign tumours, E-cadherin was strongly expressed at the intercellular borders of epithelial cells, but it was less strongly expressed in 17 (43 per cent) of the malignant tumours. Furthermore, poorly differentiated carcinomas were less immunoreactive for E-cadherin than moderately and well differentiated carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790166     DOI: 10.1136/vr.152.20.621

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Cadherin cell adhesion system in canine mammary cancer: a review.

Authors:  Adelina Gama; Fernando Schmitt
Journal:  Vet Med Int       Date:  2012-08-22

2.  Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.

Authors:  Michèle Spoerri; Franco Guscetti; Sonja Hartnack; Alois Boos; Christine Oei; Orsolya Balogh; Renata M Nowaczyk; Erika Michel; Iris M Reichler; Mariusz P Kowalewski
Journal:  BMC Vet Res       Date:  2015-09-15       Impact factor: 2.741

3.  Classification and grading of canine malignant mammary tumors.

Authors:  Abbas Tavasoly; Hannaneh Golshahi; Annahita Rezaie; Mohammad Farhadi
Journal:  Vet Res Forum       Date:  2013       Impact factor: 1.054

4.  Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.

Authors:  Ana Catarina Figueira; Catarina Gomes; Joana Tavares de Oliveira; Hugo Vilhena; Júlio Carvalheira; Augusto J F de Matos; Patrícia Dias Pereira; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2014-11-26       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.